🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary aim of this study is to investigate whether multisensory integr...
Status
Completed
Location
Azienda Ospedaliera Universitaria Integrata Verona - UOC di Neuroriabilitazione
Start Date
2018-11-07
Trial ID
NCT06690125
Treatments Being Tested
Prospective multicenter study in which all patients with borderline or loca...
Status
Recruiting
Location
Hospital General de Alicante
Start Date
2024-03-21
Trial ID
NCT06582342
This phase III trial compares stereotactic body radiation therapy (SBRT), (...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-12-14
Trial ID
NCT05946213
This phase II trial tests the effectiveness and safety of artificial intell...
Status
Recruiting
Location
Northwestern University
Start Date
2023-11-20
Trial ID
NCT05802186
This phase II trial studies how well combination chemotherapy works in trea...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2020-10-19
Trial ID
NCT04322318
Treatments Being Tested
This phase III trial compares whether the addition of pembrolizumab to radi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-04-09
Trial ID
NCT04214067
This phase I/II trial identifies the best dose and side effects of selinexo...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Start Date
2021-05-06
Trial ID
NCT04764942
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-04-15
Trial ID
NCT06094842
This phase II trial is studying how well giving irinotecan together with ci...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2003-06
Trial ID
NCT00062374
This phase I/Ib trial is to find out the best dose, possible benefits and/o...
Status
Suspended
Location
National Cancer Institute Developmental Therapeutics Clinic
Start Date
2022-02-02
Trial ID
NCT04840589